MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

April 2014


Evaluation of Discharge Medication Orders Following Automatic Therapeutic Substitution of Commonly Exchanged Drug Classes

In a retrospective chart review of adult patients admitted to an academic medical center, 15% of the 317 patients identified as being subject to automatic therapeutic substitution for one of five drug classes were not returned to original outpatient therapy upon discharge, and 16% were receiving a cost-prohibitive drug.
Sarah Glaholt, PharmD; Genevieve L. Hayes, PharmD, BCPS; and Christopher S. Wisniewski, PharmD, BCPS

The Pharmaceutical Industry Tussles Over Biosimilars

Federal and State Decisions Will Have a Big Impact on Pharmacists

Unlike a generic drug, a “generic” biologic won’t be identical to the branded product. Manufacturers are divided over whether pharmacists should have to tell doctors when they prescribe one of the “biosimilars” that will soon appear on the market.
Stephen Barlas


Carlos Fernández-del Castillo Confronts the Challenge of Pancreatic Cancer

Although Progress Has Been Slow, a Renowned Expert on the Disease Sees Reasons for Hope

The prognosis for patients with pancreatic cancer remains poor, but a widely recognized expert on pancreatic and biliary surgery at Massachusetts General Hospital and Harvard Medical School expresses optimism about improvements in the next decade.
Jack McCain


Hypertension: Is It Time to Replace Drugs with Nutrition and Nutraceuticals?

Many hypertension patients want to learn about ways to reduce reliance on pharmaceuticals, says functional medicine practitioner Mark Houston, who believes it is often possible to reduce or eliminate reliance on drugs using nutrition and nutraceuticals.
Walter Alexander


Medication Errors

Affirmative Warnings (Do This) May Be Better Understood Than Negative Warnings (Do Not Do That)

Matthew Grissinger, RPh, FaScP

Prescription: Washington

Federal Investigative Report Questions 340B Contract Pharmacy Programs

Office of Pharmacy Affairs Promises Regulatory Response

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Ibrutinib (Imbruvica) for chronic lymphocytic leukemia, tasimelteon (Hetlioz) for non-24-hour sleep–wake disorder, and anti-inhibitor coagulant complex (Feiba) to prevent or reduce bleeding in hemophilia A or B
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Suvorexant, a Dual Orexin Receptor Antagonist for the Management of Insomnia

Tiffany Bennett, David Bray, and Michael W. Neville, PharmD, BCPS, FASHP